EFGCP Webinar – Paediatric Clinical Trial Preparedness

Datum: 11 February 2021

Tijd: 17:00-18:30 CEST

Locatie: Webinar

Delays in conducting and completing paediatric clinical trials are one of the major challenges researchers are facing when developing new medicines for children. The EMA Paediatric Action Plan has addressed this issue by commissioning a new guidance document to the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) that sets out recommendations for clinical trial preparedness focusing on factors which facilitate or hamper the conduct of trials in children. "Trial preparedness" is defined as a structured assessment of the key factors that could increase the likelihood of a smooth and timely course of a paediatric clinical trial, integrating information from multiple stakeholders on what is possible within individual studies and therefore also for the overall drug development plan within which a trial is embedded. These recommendations are moving beyond the definition of clinical trial "feasibility" to present a global determination of all aspects of a trial that need to be prepared with the active involvement and collaboration of all stakeholders. Active discussion of these aspects within all regulatory applications will also help resolving some of the hurdles faced during such interactions. In this webinar, members of the Enpr-EMA working group for this guidance will discuss these recommendations and provide some practical insights from for Industry, Research Networks and Patients, how to operationalize these ideas in practice.

Continue Reading

EFGCP: Independent Data Monitoring Committee IDMC/DSMB Challenges during COVID pandemic

Datum: 19 October 2020

Tijd: 17.00 - 18.00 CEST

Locatie: Webinar

Agenda & Presenters:
> Basic introduction to regulatory requirements for IDMC / Seif Eddine Amara Madi, GSK Biologicals
> Common findings relating to IDMC/DSMB during audits and inspections / Louise Mawer, Mirabilitas Ltd
> Main challenges for IDMC expert during COVID-19 / Stephen Toovey, Pegasus Medical & Scientific Services
> IDMCs/DSMBs: a short research ethics primer / Heather Sampson, University of Toronto
> Main challenge for IDMC management a sponsor perspective (TBC)
> Q&A, Discussions

Continue Reading

EFGCP & DIA: Better Medicines for Children Conference

Startdatum: 12 October 2020

Einddatum: 13 October 2020

Locatie: Online

This year, in 2020, 13 years after the EU Paediatric Regulation came into force, our aim is to build on achievements and lessons learnt so far and to look at the future of paediatric drug development, with a specific focus on putting patients at the heart of innovation and regulatory science.

Continue Reading